Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nucleic acid structure and expression carrier for enhancing recombinant protein production and mass-production method of recombinant protein

A technology of nucleic acid constructs and recombinant vectors, applied in hemoglobin/myoglobin, using vectors to introduce foreign genetic material, biochemical equipment and methods, etc., can solve problems such as difficulties, achieve promotional efficiency, shorten time, and facilitate cultivation The effect of the operation

Inactive Publication Date: 2008-07-30
FENG CHIA UNIVERSITY
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] However, to the applicant's knowledge, there are still difficulties in achieving the goal of high yields of recombinant proteins with the techniques currently available in the field of biotechnology

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid structure and expression carrier for enhancing recombinant protein production and mass-production method of recombinant protein
  • Nucleic acid structure and expression carrier for enhancing recombinant protein production and mass-production method of recombinant protein
  • Nucleic acid structure and expression carrier for enhancing recombinant protein production and mass-production method of recombinant protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0110] Example 1. Construction of an expression plasmid comprising the Vitella hyaline hemoglobin structural gene (vgb) and thioredoxin structural gene (trxA)

[0111] Experimental Materials:

[0112] The intermediate cells (intermediate cells) used in the DNA cloning process were Escherichia coli (Escherichia coli) XL1-Blue (Stratagene Co.), and were cultured at 37°C in Luria-Bertani (LB) medium (Miller, J.H. (1972 ), Experiments in Molecular Genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY), then the transformed Escherichia coli was cultured in the medium supplemented with antibiotics (the dosage of antibiotics was 15 μg / mL for streptomycin, and 15 μg / mL for ampicillin Penicillin was used at 50 μg / mL).

[0113] Vitreoscilla sp. (Murray strain no.389) was donated by Dr. Webster (Department of Biology, Illinois Institute of Technology, Chicago, USA), and cultured at 30°C in a medium containing 1.5% yeast Extract (yeast extract), 1.5% peptone (peptone) and 0.02...

Embodiment 2

[0149] Example 2. Production of thioredoxin, Vitreola hemoglobin, and fusion protein of thioredoxin and Vitiligo hemoglobin with Escherichia coli

[0150] The recombinant plasmids pGB-VHb, pGB-Trx, pGB-TV1 and pGB-TV2 obtained in Example 1 were respectively transformed into Escherichia coli strain BL21(DE3) according to the plasmid transformation method described in the "General Experimental Method" above. (Novagen Co.), and obtained recombinant strains BL21(DE3) / pGB-VHb, BL21(DE3) / pGB-Trx, BL21(DE3) / pGB-TV1 and BL21(DE3) / pGB-TV2.

[0151] Colonies of each recombinant strain were selected from the solid-state culture dish, inoculated into 5 mL of LB medium containing 15 μg / mL streptomycin, and cultured overnight at 37°C. Afterwards, the overnight cultured cells were inoculated into a 250 mL flask containing 20 mL of LB medium (containing 15 μg / mL streptomycin), and when the initial cell density reached 0.05 (OD 550 ), culture the newly inoculated bacteria solution in a consta...

Embodiment 3

[0160] Example 3. Production of heterologous protein -- human interferon alpha 2 with transformed Escherichia coli

[0161] The plasmid pET-IFN contains a T 7 promoter to control the expression of the human interferon α2 structural gene, and its construction method is described below.

[0162] The following two primers were synthesized according to the nucleotide sequence of the human interferon α2 structural gene (E.Austruy et al. (1998), Cancer Gene Ther.5:247-256):

[0163] forward primer

[0164] 5'-tgctctcatatgttg atctgcctcaaac-3' (SEQ ID NO: 5)

[0165] reverse primer

[0166] 5'-cgtgctcgag ttaattattccttacttcttaaac-3' (SEQ ID NO: 6)

[0167] The above two primers were designed to have cleavage sites for restriction enzymes NdeI and XhoI (marked underlined), respectively.

[0168] to use The plasmid pIFN2A purified by the Spin Miniprep kit (obtained from Professor Xu Zuan of the National Institutes of Health, which contains the human interferon α2 gene introduced in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Nucleic acid construction and expression carrier for improving recombinant protein production and production of recombinant protein are disclosed. The process is carried out by cloning first nucleic acid sequence of coded thioredoxin and second nucleic acid sequence of coded ferrohemoglobin into recombinant host cell, reinforcing the recombinant host cell production and helping to release intracellular stress.

Description

technical field [0001] The present invention discloses nucleic acid constructs and expression vectors for improving the production of recombinant polypeptide / protein (recombinantpolypeptide / protein), as well as methods for mass production of recombinant polypeptide / protein, wherein one of the first encoding thioredoxin (thioredoxin) The nucleic acid sequence and a second nucleic acid sequence encoding hemoglobin are cloned into a recombinant host cell, thereby enhancing the productivity of the recombinant host cell to produce a selected gene product and helping the recombinant host cell to alleviate the excess of the gene product Intracellular stress due to production. Background technique [0002] "Production of recombinant polypeptide / protein" can be regarded as a very important genetic engineering technology in the field of biotechnology. Its basic principle is to express a desired gene product (for example, industrial and agricultural enzymes, therapeutic proteins, The ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/63C12N15/67C07K14/805C12N5/10C12N9/02C12N15/70
CPCC07K14/805C07K2319/00C12N15/67C12N15/70C12N9/0036
Inventor 赵云鹏王祉雯陈柏庭陈裕星
Owner FENG CHIA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com